The FDA has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to ...
Patients can use the headset themselves in their homes to counteract moderate to severe depression, with what the FDA says ...
ARR increased 34% year-over-year to $754 millionQ3 revenue increased 33% year-over-year to $184.2 millionSurpassed $1 billion in Remaining Performance Obligations, reflecting 41% year-over-year ...
The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback